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Mental illness: South Africa’s blind spot
To the Editor: The articles by Odendaal et al.[1] and Pillay-van 
Wyk et al.[2] indicate poor recognition of mental illness and its 
complex interplay with physical health in South African (SA) 
research. While Odendaal et al.[1] screened for depression in preg-
nant women, the relationship between mental illness and persistent 
smoking was not explored and the possible need to tailor interven-
tions to perceptual, cognitive or personality functioning was not 
discussed. Pillay-van Wyk et al.[2] include mental illness among ‘other’ 
comorbidities in COVID-19 deaths, but do not mention substance 
use. Furthermore, they do not discuss the low prevalence of these 
comorbidities among COVID-19 deaths, although it is an unexpected 
finding given the excess mortality associated with mental disorders.[3] 
In pregnancy, mental disorders are associated with preterm 
delivery, low birth weight, hypertension, gestational diabetes and 
neonatal morbidity.[4-6] The extent to which these outcomes are 
mediated by smoking and/or social deprivation is unknown. Smoking 
is more prevalent among people with mental illness (PWMI) than in 
the general population, with more intense addiction and reduced 
response to population-level interventions.[7,8] Mental illness is also 
associated with social deprivation. The association between persistent 
smoking and social deprivation found by Odendaal et al.[1] is similar 
to that found in Canada among PWMI,[9] and is consistent with the 
well-documented mental health/poverty cycle[10] (related to social 
exclusion as well as social and/or occupational impairment). 
While mental healthcare may improve socioeconomic outcomes 
among PWMI,[10] it alone does not reduce smoking. Neither does 
education. However, behavioural and pharmacological interventions 
may. Prochaska et al.[8] discuss the application of the Host-Agent-
Vector-Environment (HAVE) public health model to smoking 
cessation among PWMI. The four domains of this application are:
• ‘Host – tobacco user characteristics (e.g. biobehavioural, social/
cognitive, mental health).
• Agent – tobacco product characteristics (e.g. nicotine content, 
delivery, flavourings).
• Vector – tobacco industry efforts (e.g. research, develop ment, 
advertising, distribution).
• Environment – broader community and policy structures (e.g. 
taxation, smoking bans, insurance coverage, retailers).’[8]
In SA, collaborative biopsychosocial Host interventions are lacking.
Regarding mortality, compared with the general population, all-cause 
mortality is doubled among PWMI, with a 10 - 20-year reduced life 
expectancy.[3] Recent US database studies found, in their population, 
higher COVID-19 mortality rates among people with psychiatric[11,12] or 
substance use disorders[13] compared with those without such disorders. 
As with the study by Pillay-van Wyk et al.,[2] their findings are dependent 
on accurate death records. While such accuracy is lacking for most 
conditions in SA, it is particularly so for mental disorders. During the 
investigation by the Ombudsman for Health in the Life Esidimeni 
tragedy, even unmissable, profoundly severe mental, neurological or 
intellec tual disability was not considered an underlying cause of death 
by those completing certificates.[14] In a country where it is estimated 
that <10% of PWMI needing mental healthcare access it,[15] what is the 
possibility that comorbid mental illness was recorded in COVID-19 
deaths?
In discussing costs of COVID-19 on our quadruple burden of 
disease, Hofman and Madhi[16] mention psychological ramifications, 
but not mental illness. This omission might be related to difficulty 
in quantifying mental illness, paucity of data or scant interrogation 
in physical health research. Perhaps mental illness is assumed 
to fall under non-communicable diseases, or maybe it is not 
perceived as integral to our disease burden. Nevertheless, omitting 
discussion on COVID-19 costs regarding incident mental illness; 
compromised access to maintenance treatment, increased relapse 
and hospitalisation; and the vulnerability of PWMI to substance use, 
assault, homelessness and mortality, keeps mental illness in our blind 
spot. How then will it feature in co-ordinated, collaborative research 
and healthcare planning?
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